Meet Samuel – Your Personal Investing Prophet
- Start a conversation with TipRanks’ trusted, data-backed investment intelligence
- Ask Samuel about stocks, your portfolio, or the market and get instant, personalized insights in seconds
Guangzhou Baiyunshan Pharmaceutical Holdings Company ( (HK:0874) ) has issued an announcement.
Guangzhou Baiyunshan Pharmaceutical Holdings Company Limited has announced a proposed final ordinary cash dividend of RMB 0.45 per share for the financial year ended 31 December 2025. Key dates and details, including the Hong Kong dollar equivalent amount, exchange rate, record date, ex-dividend date, book closure period, payment date, and applicable withholding tax arrangements, will be announced later, signaling an ongoing commitment to shareholder returns while final mechanics remain pending shareholder approval.
The dividend proposal underscores the company’s intention to distribute profits to investors following its 2025 financial performance, which may support its attractiveness to income-focused shareholders in the pharmaceutical sector. As a Hong Kong-listed issuer, Guangzhou Baiyunshan’s detailed timetable for dividend entitlement, processing via its Hong Kong share registrar, and confirmation of tax treatment will be important for both local and overseas investors in planning their holdings and expected cash flows.
The most recent analyst rating on (HK:0874) stock is a Hold with a HK$20.00 price target. To see the full list of analyst forecasts on Guangzhou Baiyunshan Pharmaceutical Holdings Company stock, see the HK:0874 Stock Forecast page.
More about Guangzhou Baiyunshan Pharmaceutical Holdings Company
Guangzhou Baiyunshan Pharmaceutical Holdings Company Limited is a Hong Kong-listed pharmaceutical company engaged in the production and distribution of medicines and related healthcare products. The group operates in the broader healthcare and pharmaceutical industry, serving both domestic and international markets through its portfolio of branded and generic drug products.
Average Trading Volume: 1,245,024
Technical Sentiment Signal: Buy
Current Market Cap: HK$44.34B
See more data about 0874 stock on TipRanks’ Stock Analysis page.